分层和选择疗法以改善严重酒精性肝炎的存活率
Ajay Kumar Mishra1, Amit Goel2
1Department of Hepatology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow 226014, Uttar Pradesh, India.
World journal of hepatology
|September 30, 2025
概括
严重的酒精性肝炎 (SAH) 具有很高的死亡风险. 本综述探讨了当前和新兴的治疗方法,强调个性化治疗选择,以改善严重酒精性肝炎患者的生存率.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 胃肠病学 胃肠病学
- 内部医学 内部医学
背景情况:
- 严重的酒精性肝炎 (SAH) 具有高的短期死亡率和异质的患者形状.
- 类固醇是SAH (MDF> 32,MELD> 20) 的标准,但其使用和适用性有限.
- 很大一部分SAH患者不适合或不对类固醇有反应,需要替代治疗.
研究的目的:
- 审查严重酒精性肝炎的护理标准.
- 讨论新兴疗法及其可变的成功率.
- 强调风险分层和适当的治疗选择的重要性,以改善SAH患者的生存率.
主要方法:
- 对严重酒精性肝炎的当前和新兴治疗方法的文献综述.
- 分析风险分层工具,用于预测SAH的结果.
- 讨论选择最佳治疗方法的挑战和策略.
主要成果:
- 类固醇是目前的标准,但不适合所有SAH患者.
- 包括G-CSF,血交换,FMT,抗生素,抗细胞因子和NAC在内的替代疗法显示出不同的疗效.
- 有效的风险分层对于指导治疗决策至关重要.
结论:
- 由于疾病异质性,改善SAH的结果仍然具有挑战性.
- 类固醇不合格和不响应率需要探索替代疗法.
- 基于风险分层的个性化治疗选择是提高严重酒精性肝炎的存活率的关键.
相关概念视频
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
185
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
185
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
214
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
214
Esophageal Varices-II: Clinical Features and Management
374
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
374
Heart Failure VI: Adjunct Therapies
261
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
261
Chronic Pancreatitis II: Collaborative Care
313
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
313
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
256
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
256


